S.R. One Ltd.

S.R. One Ltd. is an investment arm of Glaxosmithkline plc specializing in investment in emerging companies with products that are in preclinical development stage through clinical proof-of-concept. The firm prefers to invest in pharmaceuticals, biotech, healthcare, and related information technologies companies that are focused on drug discovery, development, and delivery. It seeks to invest in companies based globally with a focus on North America and Europe. The firm typically invests between $500,000 and $5 million per round and prefers to take a board seat or observers right in its portfolio companies. It seeks to lead or take an active syndicate role in its investments. S.R. One Ltd. was founded in 1985 and is based in West Conshohocken, Pennsylvania.